Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,977 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,375
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 101–150 of 5,977 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05155046	18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy	recruiting	Phase 2	130	National Cancer Institute (NCI)NIH	1	Sep 17, 2026	clinicaltrials
NCT05616650	Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor	recruiting	Phase 2	42	National Cancer Institute (NCI)NIH	1	Sep 17, 2026	clinicaltrials